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Background:  Ranolazine (RAN) by inhibiting the cardiac late sodium current, decreases left ventricular (LV) stiffness and extra-vascular 
compressive forces on coronary microcirculation and thereby, improves myocardial perfusion. Phase analysis of gated SPECT myocardial perfusion 
imaging (MPI) provides measures of LV (LV) systolic and diastolic dyssynchrony (D).This study examined the phase standard deviation (SD) and 
bandwidth (BW), the 2 indices of LVD, before and after RAN therapy in patients with coronary artery disease (CAD).
Methods:  Stress/rest MPI was performed in 32 patients (exercise, n=18 and vasodilator, n=14) with CAD before and after 4 weeks of RAN (500-
1000 mg BID). The stress images were analyzed to derive systolic and diastolic SD and BW. There were 23 men (72%), aged 65±10 yrs and the EF 
was 58±15 %. All patients had ischemia on the stress MPI.
Results:  The systolic and diastolic LVD improved significantly after RAN (Table). There was a significant correlation between the change (from 
before to after RAN treatment) in systolic vs. diastolic SD (r=0.62, p=0.0002) and the BW (r=0.53, p=0.002). There was a significant inverse 
relationship between the baseline diastolic BW with the change in diastolic BW from before to after RAN treatment (r=- 0.45, p=0.0091) 
Before-RAN After-RAN P value
Systolic Phase SD 21± 17 18 ±13 0.05
Systolic Phase BW 69 ± 61 54 ± 39 0.04
Diastolic phase SD 29 ±18 24 ± 15 0.06
Diastolic phase BW 91± 62 72 ± 46 0.03
Conclusions:  This pilot study, for the first time, shows that RAN reduces LVD. The improvement might explain the beneficial anti ischemic effects 
and the other beneficial effects of RAN and is consistent with its mechanism of action. 
